Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · July 04, 2023

Incidence of Second Primary Malignancies in Patients With Multiple Myeloma Receiving Anti-CD38 Monoclonal Antibodies

Leukemia Research


Additional Info

Disclosure statements are available on the authors' profiles:

Leukemia Research
Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis
Leuk. Res 2023 Aug 01;131(xx)107324, A Mian, SAA Naqvi, A Ayaz, M Husnain, MA Aljama, GR Mohyuddin, K Koehn, M Mohan, I Bin Riaz, R Chakraborty

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading